Gilead Highlights Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa Gilead Sciences has commended the leadership of the Government of South Africa and the Global Fund for their efforts to accelerate access to lenacapavir, a long-acting HIV…
HSS Surgeon Riley J. Williams III Appointed Venue Medical Officer for FIFA World Cup 26™ in New York–New Jersey Region FIFA World Cup 26™ has announced the appointment of Hospital for Special Surgery (HSS) Sports Medicine Surgeon Riley J. Williams…
Fujifilm Strengthens Life Sciences Leadership Across Biomanufacturing and iPSC Businesses FUJIFILM Holdings America Corporation has announced expanded leadership responsibilities for three senior executives across its Life Sciences Group, reinforcing the company’s strategic focus on cell therapy, biologics manufacturing, and induced…
New Evidence Supports Ketogenic Therapy as a Potential Treatment for Anorexia Nervosa A pilot clinical study published in Communications Medicine has reported promising early evidence that a ketogenic nutritional intervention may be both safe and potentially beneficial for individuals with…
Niagen Bioscience Renames Research Program to Strengthen Global Commitment to NAD+ Science and Healthy Aging Research Niagen Bioscience, Inc. (NASDAQ: NAGE), a company focused on advancing the science of healthy aging through research on nicotinamide adenine dinucleotide (NAD+), has announced…
Iza-Bren Significantly Improves Overall and Progression-Free Survival in Triple-Negative Breast Cancer and Esophageal Cancer SystImmune, Inc., a clinical-stage biotechnology company focused on developing innovative cancer therapies, and Bristol Myers Squibb have announced encouraging results from two pivotal Phase 3 clinical…
Novel Blood Test Reveals Key Tumor Microenvironment Signals Predictive of Immunotherapy Outcomes in Sarcoma Aqtual, Inc., a precision medicine company focused on developing advanced cell-free DNA (cfDNA) diagnostics for oncology and chronic diseases, has announced new research findings demonstrating the…
Lysoway Therapeutics Secures Additional MJFF Funding to Advance TMEM175 Agonist Program for Parkinson’s Disease Lysoway Therapeutics, a biopharmaceutical company focused on developing small-molecule therapies that target lysosomal ion channels, has announced that it has received an additional research grant from…
Meiji Seika Pharma Invests in Global Health Security Fund to Advance Pandemic Preparedness and Infectious Disease Innovation Meiji Seika Pharma Co., Ltd., one of Japan’s leading pharmaceutical companies with a long-standing focus on infectious disease research and development, has announced…
Pfizer and Innovent Biologics Forge Major Global Oncology Partnership to Advance Next-Generation Cancer Medicines Pfizer Inc. and Innovent Biologics have announced a landmark strategic global licensing and collaboration agreement aimed at accelerating the discovery, development, and commercialization of a new…
BeOne Medicines Reports Phase 3 HERIZON-GEA Results Published in NEJM and Featured at ASCO 2026 BeOne Medicines has announced the publication and upcoming presentation of significant new clinical data from the HERIZON-GEA-01 trial evaluating ZIIHERA in combination with chemotherapy, with…
Cosm Medical Enters Licensing and Collaboration Agreement to Advance Personalized Gynethotics™ Devices for Post-Surgical Pelvic Recovery Cosm Medical Corp. has announced a new licensing and collaboration agreement with Duke Health and Mayo Clinic aimed at developing and commercializing a new…